Literature DB >> 2457117

Serotypic analysis of VP3 and VP7 neutralization escape mutants of rhesus rotavirus.

R D Shaw1, E R Mackow, M L Dyall-Smith, I Lazdins, I H Holmes, H B Greenberg.   

Abstract

Neutralization escape mutants of simian rotaviruses (rhesus rotavirus and SA11) were tested in hemagglutination inhibition and neutralization assays against hyperimmune and infection sera to determine if mutation in an immunodominant epitope could enable neutralization escape. An SA11 mutant with a new glycosylation site at amino acid 211 of VP7 was shown to escape neutralization by hyperimmune but not infection sera.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2457117      PMCID： PMC253479     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  16 in total

1.  Location of the major antigenic sites involved in rotavirus serotype-specific neutralization.

Authors:  M L Dyall-Smith; I Lazdins; G W Tregear; I H Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

2.  Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3.

Authors:  B S Coulson; J M Tursi; W J McAdam; R F Bishop
Journal:  Virology       Date:  1986-10-30       Impact factor: 3.616

3.  Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7.

Authors:  P A Offit; R D Shaw; H B Greenberg
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

4.  Rotavirus neutralizing protein VP7: antigenic determinants investigated by sequence analysis and peptide synthesis.

Authors:  P R Gunn; F Sato; K F Powell; A R Bellamy; J R Napier; D R Harding; W S Hancock; L J Siegman; G W Both
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

5.  Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses.

Authors:  K Taniguchi; S Urasawa; T Urasawa
Journal:  J Gen Virol       Date:  1985-05       Impact factor: 3.891

6.  Demonstration of an immunodominant neutralization site by analysis of antigenic variants of SA11 rotavirus.

Authors:  I Lazdins; S Sonza; M L Dyall-Smith; B S Coulson; I H Holmes
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

7.  Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3.

Authors:  R D Shaw; D L Stoner-Ma; M K Estes; H B Greenberg
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

8.  The major surface glycoprotein of simian rotavirus (SA11) contains distinct epitopes.

Authors:  S Sonza; A M Breschkin; I H Holmes
Journal:  Virology       Date:  1984-04-30       Impact factor: 3.616

9.  Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus.

Authors:  H B Greenberg; J Valdesuso; K van Wyke; K Midthun; M Walsh; V McAuliffe; R G Wyatt; A R Kalica; J Flores; Y Hoshino
Journal:  J Virol       Date:  1983-08       Impact factor: 5.103

10.  Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus.

Authors:  R L Ward; D R Knowlton; G M Schiff; Y Hoshino; H B Greenberg
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103
View more
  11 in total

1.  Typing of human rotavirus VP4 by an enzyme immunoassay using monoclonal antibodies.

Authors:  B S Coulson
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

2.  Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus.

Authors:  R L Ward; D R Knowlton; H B Greenberg; G M Schiff; D I Bernstein
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

Review 3.  Rotavirus gene structure and function.

Authors:  M K Estes; J Cohen
Journal:  Microbiol Rev       Date:  1989-12

4.  Comparative studies of the antigenic polypeptide species VP4, VP6, and VP7 of three strains of bovine rotavirus.

Authors:  S L Zheng; G N Woode; D R Melendy; R F Ramig
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

5.  The cytokine osteopontin modulates the severity of rotavirus diarrhea.

Authors:  Ellen E Rollo; Scott J Hempson; Ajay Bansal; Ernest Tsao; Iman Habib; Susan R Rittling; David T Denhardt; Erich R Mackow; Robert D Shaw
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant.

Authors:  E R Mackow; J W Barnett; H Chan; H B Greenberg
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

7.  Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge.

Authors:  E R Mackow; P T Vo; R Broome; D Bass; H B Greenberg
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

8.  VP4-specific intestinal antibody response to rotavirus in a murine model of heterotypic infection.

Authors:  R D Shaw; W S Groene; E R Mackow; A A Merchant; E H Cheng
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

9.  Immunogenicity, antigenicity, and protection efficacy of baculovirus expressed VP4 trypsin cleavage products, VP5(1)* and VP8* from rhesus rotavirus.

Authors:  S J Dunn; L Fiore; R L Werner; T L Cross; R L Broome; F M Ruggeri; H B Greenberg
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

10.  Expression of the rotavirus SA11 protein VP7 in the simple eukaryote Dictyostelium discoideum.

Authors:  K R Emslie; J M Miller; M B Slade; P R Dormitzer; H B Greenberg; K L Williams
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.